It is planned to include almost 200 patients with proven SARS-CoV-2 infection, all of whom will be monitored with the cosinuss° Two in-ear sensor throughout the entire course of the disease (approx. 8-12 weeks) – including treatment and recovery in the post-stationary period (project arm II).
Prior to this, a validation of the sensor against the gold standard will take place in the intensive care unit (project arm I). In addition, a further application is planned following the study: Here, our sensor technology will be tested for monitoring healthcare workers showing SARS-CoV-2 associated symptoms (project arm III).
The non-interventional observational study will be conducted at the Klinikum Großhadern of the LMU Munich, coordinated by PD Dr. R. Schniepp (Department of Neurology) and Dr. Ines Speck (Department of Anesthesiology). The study is funded by own budget.